.png)
Who is this course for?
+ General audiences + Researchers and clinicians + Students and educators + Public-health and harm-reduction practitioners + Policy, nonprofit, and community professionals
.png)
Format & length
• On-demand, self-paced course • Approximately 1.5 hours of recorded course content • Recorded Q&A from the original live session included
Date & time / Pricing info
• On Demand $79 • Learn at your own pace after release
What do you get when you enroll?
• Immediate enrollment in the on-demand course • Recorded course content featuring insights from a clinical research professional working in the psychedelic field • Learn at your own pace and return to the material throughout your course access period
By taking this course, you will be able to:
• Assess the design and reported outcomes of psychedelic clinical trials, including limitations affecting participant experience and real-world application. • Describe the structural, ethical, regulatory, and logistical challenges that shape psychedelic clinical research. • Compare conventional clinical-trial methods with emerging approaches intended to improve inclusion, ecological validity, and continuity of care. • Critique the representation of sex, gender, culture, and community perspectives in psychedelic trial design and reporting.
Meet your instructor
Tali Avron Clinical Research Advisor and Educator Tali Avron is a clinical research advisor and educator with more than 15 years of experience spanning pharmaceutical clinical trials, cannabinoid medicine, and psychedelic research. She has led international clinical operations across academia, biotech, contract research organizations, and nonprofit organizations, focusing on mental health and innovative therapeutics. Tali previously served as Clinical Trial Manager at MAPS Europe, overseeing multinational MDMA-assisted psychotherapy trials for PTSD across Europe. Today, she advises organizations working at the intersection of psychedelic science, research, and public health while consulting on clinical development, research strategy, and the responsible implementation of novel therapies. She is the co-founder of Psychedelic Women Network and Expanding Consciousness, an educational initiative dedicated to bringing evidence-based psychedelic science to public and professional audiences. Tali also supports harm-reduction services and community education and is passionate about translating complex clinical research into practical, accessible knowledge.
Course outline
• Course Introduction Meet your instructor and receive an overview of the course, its central questions, and the current psychedelic-research landscape. • Foundations and Challenges Explore the history and political context of psychedelic research, the anatomy of a clinical trial, and the scientific, regulatory, ethical, financial, and logistical challenges that shape trial design. • Inclusive Research and Emerging Models Examine sex, gender, culture, participant selection, community perspectives, continuity of care, real-world evidence, and emerging approaches to psychedelic research. • Learning From Mistakes and Looking Forward Consider complex trial cases, transparency, negative findings, meaningful outcome measures, unmet needs, and principles for improving future psychedelic research.
On Demand Available October 6
On Demand Available Now Inside Psychedelic Clinical Trials: Science, Context, and Critical Reflections
$79.00